BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37160841)

  • 21. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.
    Guarnieri V; Seaberg RM; Kelly C; Jean Davidson M; Raphael S; Shuen AY; Baorda F; Palumbo O; Scillitani A; Hendy GN; Cole DEC
    BMC Med Genet; 2017 Aug; 18(1):83. PubMed ID: 28774260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism.
    Masi G; Barzon L; Iacobone M; Viel G; Porzionato A; Macchi V; De Caro R; Favia G; Palù G
    Endocr Relat Cancer; 2008 Dec; 15(4):1115-26. PubMed ID: 18755853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
    Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
    Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent hyperparathyroidism and a novel nonsense mutation in a patient with hyperparathyriodism-jaw tumor syndrome.
    Abdulla AG; O'Leary EM; Isorena JP; Diaz MF; Yeh MW
    Endocr Pract; 2013; 19(6):e134-7. PubMed ID: 23757631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperparathyroidism-jaw tumor syndrome: a report of three large kindred.
    Iacobone M; Masi G; Barzon L; Porzionato A; Macchi V; Ciarleglio FA; Palù G; De Caro R; Viel G; Favia G
    Langenbecks Arch Surg; 2009 Sep; 394(5):817-25. PubMed ID: 19529956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid carcinoma: a clinical and genetic perspective.
    Cetani F; Pardi E; Marcocci C
    Minerva Endocrinol; 2018 Jun; 43(2):144-155. PubMed ID: 28949121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Young Male with Parafibromin-Deficient Parathyroid Carcinoma Due to a Rare Germline HRPT2/CDC73 Mutation.
    Kapur A; Singh N; Mete O; Hegele RA; Fantus IG
    Endocr Pathol; 2018 Dec; 29(4):374-379. PubMed ID: 30361844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
    Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
    J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAJOR MOLECULAR GENETIC DRIVERS IN SPORADIC PRIMARY HYPERPARATHYROIDISM.
    Arnold A
    Trans Am Clin Climatol Assoc; 2016; 127():235-244. PubMed ID: 28066056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
    Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
    Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism.
    Bricaire L; Odou MF; Cardot-Bauters C; Delemer B; North MO; Salenave S; Vezzosi D; Kuhn JM; Murat A; Caron P; Sadoul JL; Silve C; Chanson P; Barlier A; Clauser E; Porchet N; Groussin L;
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E403-8. PubMed ID: 23293331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features.
    Le Collen L; Barraud S; Braconnier A; Coppin L; Zachar D; Boulagnon C; Deguelte S; Souchon PF; Spodenkiewicz M; Poirsier C; Aubert S; Odou MF; Delemer B
    Endocrine; 2021 Sep; 73(3):693-701. PubMed ID: 33999366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.
    Korpi-Hyövälti E; Cranston T; Ryhänen E; Arola J; Aittomäki K; Sane T; Thakker RV; Schalin-Jäntti C
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3044-8. PubMed ID: 24823466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors.
    Siu WK; Law CY; Lam CW; Mak CM; Wong GW; Ho AY; Ho KY; Loo KT; Chiu SC; Chow LT; Tong SF; Chan AY
    Fam Cancer; 2011 Dec; 10(4):695-9. PubMed ID: 21732217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
    Cetani F; Pardi E; Ambrogini E; Lemmi M; Borsari S; Cianferotti L; Vignali E; Viacava P; Berti P; Mariotti S; Pinchera A; Marcocci C
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
    Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone.
    Cetani F; Pardi E; Marcocci C
    Endocrinol Metab Clin North Am; 2021 Dec; 50(4):683-709. PubMed ID: 34774241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approach to the Patient With Parathyroid Carcinoma.
    Cetani F; Pardi E; Torregrossa L; Borsari S; Pierotti L; Dinoi E; Marcocci C
    J Clin Endocrinol Metab; 2023 Dec; 109(1):256-268. PubMed ID: 37531615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parathyroid Carcinoma.
    Cetani F; Pardi E; Marcocci C
    Front Horm Res; 2019; 51():63-76. PubMed ID: 30641523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.